ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.

Alfasigma S.p.A. · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
prevention
diverticulitis, recurrent acute diverticulitis, prevention, diverticular complications, rifaximin delayed release, sibo, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 870134
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.